ENDRA Life Sciences Inc. — Director's Dealing 2021

Jan 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2021-01-05

Reporting Person: Wells David R. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-05	Common Stock	S	100	$0.90	Disposed	114903	Direct
2021-01-06	Common Stock	S	34900	$0.90	Disposed	80003	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	24786	Indirect

Footnotes

F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan in order to pay the tax liability associated with the vesting of restricted stock units which were granted to the Reporting Person on April 9, 2020.